Bilirubin scavenges chloramines and inhibits myeloperoxidase-induced protein/lipid oxidation in physiologically relevant hyperbilirubinemic serum.

作者: A.C. Boon , C.L. Hawkins , J.S. Coombes , K.H. Wagner , A.C. Bulmer

DOI: 10.1016/J.FREERADBIOMED.2015.05.031

关键词:

摘要: Hypochlorous acid (HOCl), an oxidant produced by myeloperoxidase (MPO), induces protein and lipid oxidation, which is implicated in the pathogenesis of atherosclerosis. Individuals with mildly elevated bilirubin concentrations (i.e., Gilbert syndrome; GS) are protected from atherosclerosis, cardiovascular disease, related mortality. We aimed to investigate whether exogenous/endogenous unconjugated (UCB), at physiological concentrations, can protect proteins/lipids oxidation induced reagent enzymatically generated HOCl. Serum/plasma samples supplemented exogenous UCB (≤250µM) were assessed for their susceptibility HOCl MPO/H2O2/Cl(-) measuring chloramine, carbonyl, malondialdehyde (MDA) formation. hyperbilirubinemic Gunn rats humans GS also exposed to: (1) validate vitro data (2) determine relevance endogenously preventing oxidation. Exogenous dose-dependently (P<0.05) inhibited MPO/H2O2/Cl(-)-induced chloramine Albumin-bound efficiently specifically (3.9-125µM; P<0.05) scavenged taurine, glycine, N-α-acetyllysine chloramines. These results translated into rat serum/plasma, showed significantly (P<0.01) reduced formation after MPO-induced Protein carbonyl MDA was MPO plasma (P<0.05; 25 50µM, respectively). Significant inhibition demonstrated within range UCB, providing a hypothetical link protection atherosclerosis individuals. demonstrate novel physiologically relevant mechanism whereby could inhibit modification quenching chloramines

参考文章(65)
J Neužil, J M Gebicki, R Stocker, Radical-induced chain oxidation of proteins and its inhibition by chain-breaking antioxidants. Biochemical Journal. ,vol. 293, pp. 601- 606 ,(1993) , 10.1042/BJ2930601
J. A. Berliner, M. Territo, A. Amdalibi, M. Navab, F. Liao, S. Cushing, S. Imes, J. Kim, B. Van Lenten, A. J. Lusis, A. M. Fogelman, Modified Lipoproteins and Atherogenesis Springer, London. pp. 77- 81 ,(1992) , 10.1007/978-1-4471-1909-8_7
Ernst Malle, Georg Waeg, Renate Schreiber, Elisabeth F. Gröne, Wolfgang Sattler, Hermann-Josef Gröne, Immunohistochemical evidence for the myeloperoxidase/H2O2/halide system in human atherosclerotic lesions. Colocalization of myeloperoxidase and hypochlorite-modified proteins FEBS Journal. ,vol. 267, pp. 4495- 4503 ,(2000) , 10.1046/J.1432-1327.2000.01498.X
Marijn C. Meuwese, Erik S.G. Stroes, Stanley L. Hazen, Joram N. van Miert, Jan Albert Kuivenhoven, Robert G. Schaub, Nicholas J. Wareham, Robert Luben, John J.P. Kastelein, Kay-Tee Khaw, S. Matthijs Boekholdt, Serum Myeloperoxidase Levels Are Associated With the Future Risk of Coronary Artery Disease in Apparently Healthy Individuals: The EPIC-Norfolk Prospective Population Study Journal of the American College of Cardiology. ,vol. 50, pp. 159- 165 ,(2007) , 10.1016/J.JACC.2007.03.033
J.R. Wagner, P.A. Motchnik, R. Stocker, H. Sies, B.N. Ames, The oxidation of blood plasma and low density lipoprotein components by chemically generated singlet oxygen. Journal of Biological Chemistry. ,vol. 268, pp. 18502- 18506 ,(1993) , 10.1016/S0021-9258(17)46655-5
AC Bulmer, JS Coombes, JT Blanchfield, I Toth, RG Fassett, SM Taylor, Bile pigment pharmacokinetics and absorption in the rat: therapeutic potential for enteral administration British Journal of Pharmacology. ,vol. 164, pp. 1857- 1870 ,(2011) , 10.1111/J.1476-5381.2011.01413.X
Ladislav Novotný, Libor Vítek, Inverse Relationship Between Serum Bilirubin and Atherosclerosis in Men: A Meta-Analysis of Published Studies: Experimental Biology and Medicine. ,vol. 228, pp. 568- 571 ,(2003) , 10.1177/15353702-0322805-29
H A Schwertner, W G Jackson, G Tolan, Association of low serum concentration of bilirubin with increased risk of coronary artery disease. Clinical Chemistry. ,vol. 40, pp. 18- 23 ,(1994) , 10.1093/CLINCHEM/40.1.18